Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05973500 · ClinicalTrials.gov registry record · NA
Effect of Mediterranean Diet in Inflammatory Bowel Disease
A NA study of Inflammatory Bowel Disease, sponsored by University of California, San Diego.
- Recruiting
- Registry status
- NA
- Development phase
- 90
- Enrollment target
- 1
- Study location
NCT05973500: Recruiting NA study of Inflammatory Bowel Disease, sponsored by University of California, San Diego.
NCT05973500 is a NA study of Inflammatory Bowel Disease that is actively recruiting participants, run by University of California, San Diego. The registered enrollment target is 90 participants, below the 401-participant average among 28 other Inflammatory Bowel Disease trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05973500, a NA study of Inflammatory Bowel Disease, is actively recruiting participants, sponsored by University of California, San Diego.
- RECRUITING
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
- 1
- Study location
Study Summary
The effects of diet on inflammatory bowel disease is an under-studied area of research. The investigators are interested in further investigating the role that diet contributes to inflammatory bowel disease severity. The investigators will collect blood and stool samples from patients with inflammatory bowel disease (IBD) before and after diet changes. The stool samples will be analyzed using metabolomics and microbiome analysis to determine changes after the new diet has been implemented. The investigators will then compare changes in the patient's overall disease state by measuring markers of inflammation including C-reactive protein (CRP) and fecal calprotectin to determine how this diet affects the disease state.
Primary Outcome
Mild to moderate Crohn's Disease is defined by a short Crohn's Disease activity index (sCDAI) between 150-450, while those in remission from Crohn's Disease have an sCDAI score below 150. An sCDAI score exceeding 450 is used as a marker of severe Crohn's Disease.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Mediterranean Diet
Study Locations (1)
California
- University of California, San Diego - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2023-09-01 |
| Est. Completion | 2028-08-01 |
| Phase | NA |
What NCT05973500 shows while recruiting
NCT05973500 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 401-participant average among 28 other Inflammatory Bowel Disease trials with a reported enrollment target (78% lower).
The record links to 1 condition, with Inflammatory Bowel Disease appearing as the primary indexed condition, and to 1 intervention - of which Mediterranean Diet is the first listed.
NCT05973500 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05973500 about?
NCT05973500 is a clinical study titled "Effect of Mediterranean Diet in Inflammatory Bowel Disease". The effects of diet on inflammatory bowel disease is an under-studied area of research. The investigators are interested in further investigating the role that diet contributes to inflammatory bowel disease severity. The investigators will collect blood and stool samples from patients with inflammat...
What is the current status of trial NCT05973500?
This trial is currently recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2023-09-01. Estimated completion is 2028-08-01.
What conditions does trial NCT05973500 study?
This clinical trial studies the following conditions: Inflammatory Bowel Disease.
What interventions are being tested in trial NCT05973500?
The interventions under investigation include: Mediterranean Diet (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05973500?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05973500 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Inflammatory Bowel Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05973500's enrollment target sits among peer trials
90 17th of 28 higher than 12 of 28 other Inflammatory Bowel Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Inflammatory Bowel Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Impact of Morning Light Therapy in IBD
RECRUITING · NA
-
A Randomized Crossover Trial of Bright Light Therapy in Crohn's Disease on Intestinal Barrier Homeostasis
RECRUITING · NA
-
The Influence of a Fasting Mimicking Diet on Ulcerative Colitis
RECRUITING · NA
-
Testing the Impact of Measurement-Based Care on Quality of Life and Disease Management Among Veterans With Inflammatory Bowel Disease
RECRUITING · NA
-
Treatment of Depressed Adolescents With Physical Illness
COMPLETED · NA
-
Pneumococcal Vaccination in Patients With Inflammatory Bowel Disease
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI